Your Position: Home > Journal List > CHINA MEDICINE > Paper

A clinical study of Haemocoagulase Acutus on wound hemostasis in abdominal operation

( views:157, downloads:0 )
Author:
XIE Shun-feng(Department of General Surgery, the Ftrst Affiliated Hospital, Medical College, Shantou Univercity, Shantou 521000, China)
YANG Tian(Department of General Surgery, the Ftrst Affiliated Hospital, Medical College, Shantou Univercity, Shantou 521000, China)
SUN Shu-ming(Department of General Surgery, the Ftrst Affiliated Hospital, Medical College, Shantou Univercity, Shantou 521000, China)
LU Xiao-feng(Department of General Surgery, the Ftrst Affiliated Hospital, Medical College, Shantou Univercity, Shantou 521000, China)
Journal Title:
CHINA MEDICINE
Issue:
Volume 5, Issue 06, 2010
DOI:
10.3760/cma.j.issn.1673-4777.2010.06.025
Key Word:
Hemocoagulase Acutus;Operation wound;Hemostasis;Randomized controlled trial

Abstract: Objective To evaluate the hemostatic role of hemocoagulase Acutus in abdominal operation and its safety and effects on coagulation on surgical patients.Methods A total of 120 patients received abdominal operation were studied prospectively by randomized, double-blind controlled and multicenter design.They were divided into Study group(60 patients) and Control group(60 patients).The Study group was given 2U Haemocoagulase and Control group was given 2U Haemocoagulase placebo 15 minutes before operation.Hemostatic time, hemorrhagic volume, hemorrhagic volume per square unit and body coagulation parameters (PT, APTT, TT, Fib and PLG) were recorded.Results The groups received different drugs.The average hemostatic time in the hemocoagulase group was 97 s, hemorrhagic volume was 1.89 g, and hemorrhagic volume per square unit was 0.048 g, significantly different (P < 0.05) from those in the Control group.Between the two groups, body coagulation parameters were not significantly different.There were no adverse events occurring.Conclusion Hemocoagulase is safe and plays a good hemostatic role in the hemorrhagic capillary in "abdominal operation.

  • [1]於东辉,步秀云,张远.等.立止血对血液的作用及毒性研究.北京医科大学学报,1994,26(4):257-258.
  • [2]李幼平,陶铁军.循证医学-21世纪临床医学与卫生决策的新支点.中国医学科学院学报,2002,24(6):548-549.
  • [3]安友仲,杨乃众,祝学光,等.外科危重病患者凝血功能障碍的防治.中华外科杂志,1996,34(6):348-351.
  • [4]朱明炜,曹金铎,贾振庚,等.蛇毒血凝酶在腹部手术中止血作用以及对凝血功能的影响.中华外科杂志,2002,40(8):581-584.
  • [5]赵鑫,毛淑芝,王志刚,等.蛇毒血凝酶对胸科手术患者凝血功能及血栓前状态的影响.山东大学学报(医学版),2005,43(2):174-175.
  • [6]容建材,廖锡瞵.立止血的药理作用、临床应用与安全性.江西医药,1994,29(5):312-315.
  • [7]Lenfors S,Gustafsson D.New model for in vivo studies of pharmaco logical interventions with endogenous fibrinolysis:effects of thrombin inhibitors.Semin Thromb Hemost,1996,2(4):335-342.
  • [8]Urano T,Ihara H,Takada Y,et al.The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha-2 antiplasmin by reptiase,a thronmbin-like venom enzvme.Blood Coagul Fibrinolysis,2000,11(2):145-153.
  • [9]Onizuka M,Ishikawa S,Ishibashi O,et al.Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor(MD805).Surg Today,1998,28(26):618-625.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn